Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,874 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.
Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V. Tsao AS, et al. Among authors: martin j. Cancer Prev Res (Phila). 2009 Nov;2(11):931-41. doi: 10.1158/1940-6207.CAPR-09-0121. Cancer Prev Res (Phila). 2009. PMID: 19892663 Free PMC article. Clinical Trial.
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
William WN Jr, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM. William WN Jr, et al. Among authors: martin jw. JAMA Oncol. 2016 Feb;2(2):209-16. doi: 10.1001/jamaoncol.2015.4364. JAMA Oncol. 2016. PMID: 26540028 Free PMC article. Clinical Trial.
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.
Papadimitrakopoulou VA, Lee JJ, William WN Jr, Martin JW, Thomas M, Kim ES, Khuri FR, Shin DM, Feng L, Hong WK, Lippman SM. Papadimitrakopoulou VA, et al. Among authors: martin jw. J Clin Oncol. 2009 Feb 1;27(4):599-604. doi: 10.1200/JCO.2008.17.1850. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075276 Free PMC article. Clinical Trial.
High-dose fenretinide in oral leukoplakia.
William WN Jr, Lee JJ, Lippman SM, Martin JW, Chakravarti N, Tran HT, Sabichi AL, Kim ES, Feng L, Lotan R, Papadimitrakopoulou VA. William WN Jr, et al. Among authors: martin jw. Cancer Prev Res (Phila). 2009 Jan;2(1):22-6. doi: 10.1158/1940-6207.CAPR-08-0100. Cancer Prev Res (Phila). 2009. PMID: 19139014 Free PMC article. Clinical Trial.
Fenretinide activity in retinoid-resistant oral leukoplakia.
Lippman SM, Lee JJ, Martin JW, El-Naggar AK, Xu X, Shin DM, Thomas M, Mao L, Fritsche HA Jr, Zhou X, Papadimitrakopoulou V, Khuri FR, Tran H, Clayman GL, Hittelman WN, Hong WK, Lotan R. Lippman SM, et al. Among authors: martin jw. Clin Cancer Res. 2006 May 15;12(10):3109-14. doi: 10.1158/1078-0432.CCR-05-2636. Clin Cancer Res. 2006. PMID: 16707609 Clinical Trial.
Chemoprevention as a form of cancer control.
Toth BB, Martin JW, Lippman SM, Hong WK. Toth BB, et al. Among authors: martin jw. J Am Dent Assoc. 1993 Jul;124(7):243-6. doi: 10.14219/jada.archive.1993.0255. J Am Dent Assoc. 1993. PMID: 8335795 Review.
18,874 results
You have reached the last available page of results. Please see the User Guide for more information.